Papers
34
Total Citations
3,134
H-Index
24
About
Mazen S. Zenati stands at the forefront of robotic and minimally invasive pancreatic surgery, having dedicated his career to advancing one of the most technically demanding fields in surgical oncology. His landmark contributions include pioneering large-scale robotic pancreatic resection programs, most notably documented in his seminal reports on 250 and subsequently 500 robotic pancreatoduodenectomies — work that has collectively garnered over 580 citations and fundamentally shaped how surgeons approach these complex procedures. Zenati has rigorously demonstrated the superiority of robotic over laparoscopic distal pancreatectomy and validated robotic pancreaticoduodenectomy against open techniques across multiple institutions, providing the evidence base that has driven widespread adoption of robotic platforms. Beyond operative outcomes, he has made distinctive contributions to surgical education and quality improvement, developing mastery-based virtual reality simulation curricula and biotissue training programs that meaningfully improve trainee proficiency. His innovative work linking intraoperative technical performance grading to postoperative complication rates — particularly pancreatic fistula — has opened new frontiers in objective surgical skill assessment. Across more than a decade of research, Zenati has helped transform robotic pancreatic surgery from an experimental endeavor into a reproducible, teachable, and measurable standard of care.
Research Focus
Key Achievements
Top Papers
- 1250 Robotic Pancreatic Resections382 citations · 2013
- 2Assessment of Quality Outcomes for Robotic Pancreaticoduodenectomy368 citations · 2015
- 3
- 4
- 5500 Minimally Invasive Robotic Pancreatoduodenectomies199 citations · 2019
- 6
- 7
- 8
- 9
- 10